Insulin resistance as an independent risk factor for carotid wall thickening

Hypertension

Volumn 28, Issue 4, 1996, Pages 593-598

  Suzuki, Masaaki ^a   Shinozaki, Kazuya ^a   Kanazawa, Akio ^a   Hara, Yasushi ^a   Hattori, Yuichi ^b   Tsushima, Motoo ^a   Harano, Yutaka ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KONAN UNIVERSITY   (Japan)

Author keywords

carotid arteries; hypertension, essential; insulin resistance; lipoproteins

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CAROTID ARTERY OBSTRUCTION; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TUNICA MEDIA;

EID: 0029818676     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.4.593     Document Type: Article

References (53)

1. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
2. Shen DC, Shieh SM, Fuh MMT, Wu DA, Chen YDI, Reaven GM. Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab. 1988;66:580-583.
3. Suzuki M, Hirose J, Asakura Y, Sato A, Kageyama A, Harano Y, Omae T. Insulin insensitivity in nonobese, nondiabetic essential hypertension and its improvement by α1 blocker (bunazosin). Am J Hypertens. 1992;5:869-874.
4. Ginsberg H, Kimmerling G, Olefski JM, Reaven GM. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest. 1975;55:454-461.
5. Harano Y, Ogaku S, Kosugi K, Yasuda H, Nakano T, Kobayashi M, Hidaka H, Izumi K, Kashiwagi A, Shigeta Y. Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin and somatostatin infusion. J Clin Endocrinol Metab. 1981;52:982-987.
6. Zuniga-Guajardo S, Jimenez J, Angel A, Zinman B. Effect of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp technique. Metabolism. 1986;35:278-282.
7. Burnard B, Hurni M, Jequier E. Insulin sensitivity and glucose disposal in young normoglycemic obese subjects. Diabete Metab. 1982;8:9-14.
8. Sheu WHH, Shieh SM, Fuh MMT, Shen DDC, Jeng CY, Chen YDI, Reaven GM. Insulin resistance, glucose intolerance, and hyperinsulinemia, hypertriglyceridemia versus hypercholesterolemia. Arterioscler Thromb. 1993;13:367-370.
9. Faccini FS, Hollenbeck CB, Jeppesen J, Chen YDI, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128-1130.
10. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
11. DeFronzo RA, Ferrannini E. Insulin resistance, a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14:173-194.
12. Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Hara Y, Tsushima M, Harano Y. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation. 1995;92:1749-1757.
13. Shinozaki K, Naritomi H, Shimizu T, Suzuki M, Ikebuchi M, Sawada T, Harano Y. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke. 1996;27:37-43.
14. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyörälä K, Salonen JT, Karhapää P. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 1991;11:1068-1076.
15. Agewall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995;26:956-960.
16. Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R, Yoneda S, Kimura K, Kamada T. Ultrasonic evaluation of early carotid atherosclerosis. Stroke. 1990;21:1567-1572.
17. Ferrara LA, Mancini M, Celentano A, Galderisi M, Iannuzzi R, Marotte T, Gaeta I. Early changes of the arterial carotid wall in uncomplicated primary hypertensive patients. Arterioscler Thromb. 1994; 14:1290-1296.
18. Suurküla M, Agewall S, Fagerberg B, Wendelhag I, Widgren B, Wikstrand J, Risk Intervention Study (RIS) Group. Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in highrisk hypertensive patients. Arterioscler Thromb. 1994;14:1297-1304.
19. Grouse JR, Toole JF, McKinney WM, Dignan MB, Howard G, Kahl FR, McMahan MR, Harpold GH. Risk factors for extracranial carotid artery atherosclerosis. Stroke. 1987;18:990-996.
20. Bonithon-Kopp C, Scarabin P-Y, Taquet A, Touboul P-J, Malmejac A, Guize L. Risk factors for early carotid atherosclerosis in middleaged French woman. Arterioscler Thromb. 1991;11:966-972.
21. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG, Atherosclerosis Risk in Communities (ARIC) Study Investigators. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 1994;25:66-73.
22. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness index, the ARIC study. Circulation. 1995;91:1432-1443.
23. Wendelhag I, Wiklund O, Wikstrand J. Arterial wall thickness in familial hypercholesterolemia: ultrasound measurement of intimamedia thickness in the common carotid artery. Arterioscler Thromb. 1992;12:70-77.
24. Blankenhorn DH, Selzer RH, Crawfold DW, Barth JD, Liu C-R, Liu C-H, Mack WJ, Alaupovic P. Beneficial effects of colestipol-niacin therapy on the common carotid artery, two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation. 1993;88:20-28.
25. Gariepy J, Maassonneau M, Levenson J, Heudes D, Simon A, the Groupe de Prévention Cardio-vasculaire en Médecine du Travail. Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension. 1993;22:111-118.
26. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, McMahan MR, Thompson CJ, Heiss G, Crouse JR. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study. Circulation. 1990;82:1230-1242.
27. Howard G, Ryu JE, Evans GW, McKinney WM, Toole JF, Murros KE, Crouse JR III. Extracranial carotid atherosclerosis in patients with and without transient ischemic attacks and coronary artery disease. Arteriosclerosis. 1990;10:714-719.
28. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245-1249.
29. O'Leary D, Polak JF, Kronmal RS, Kittner SJ, Bond G, Wolfson SK, Bommet W, Price TR, Gardin JM, Savage PJ. Distribution and correlates of sonographically detected carotid artery disease in the cardiovascular health study. Stroke. 1992;23:1752-1760.
30. World Health Organization Study Group. Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1985. WHO Technical Report Series, No. 727.
31. Pignoli P. Ultrasound B-mode imaging for arterial wall thickness measurement. In: Hegyeli RJ, ed. Atherosclerosis Reviews. New York, NY: Raven Press Publishers; 1984;12:177-184.
32. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
33. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Komada M, Kajimoto Y, Morishima T, Kamada T. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes. 1994;43:634-639.
34. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, Maeda H, Handa N, Matsumoto M, Kamada T. Prevalence of carotid atherosclerosis in diabetic patients. Diabetes Care. 1992;15:1290-1294.
35. Hoffman WS. A rapid photoelectric method for the determination of glucose in blood and urine. J Biol Chem. 1937;120:52-55.
36. Hale CN, Randle PJ. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963;88:137-146.
37. Hatch FT, Lees RS. Practical method for plasma lipoprotein. Adv Lipid Res. 1968;6:1-68.
38. Richmond W. Preparation and properties of a cholesterol oxidase from Nacardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem. 1973;19:1350-1356.
39. Fletcher MJ. A colorimetric method for estimating serum triglycerides. Clin Chim Acta. 1968;22:393-397.
40. Harano Y, Nakao Y, Kageyama A, Suzuki M, Hirose J, Asakura Y, Sato A, Komatsu R, Tsushima M, Yamamoto A. A contribution of hyperinsulinemia and hyperglycemia to lipoprotein disorder in obesity. In: Oomura Y, Tarai S, Inoue S, Shimizu T, eds. Progress in Obesity Research. London, UK: John Libby; 1990:299-302.
41. SAS Institute Inc. SAS User's Guide: Statistics, Version 6. Cary, NC: SAS Institute Inc; 1989.
42. Salonen R, Seppänen K, Rauramaa R, Salonen JT. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis. 1988;8:788-792.
43. Lemne C, Jogestrand T, de Faire U. Carotid intima-media thickness and plaque in borderline hypertension. Stroke. 1995;26:34-39.
44. Dzau VJ. Mechanism of the interaction of hypertension and hypercholesterolemia in atherogenesis: the effects of antihypertensive agents. Am Heart J. 1988;116:1725-1728.
45. Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res. 1975;36:319-327.
46. Sato Y, Shiraishi S, Oshida Y, Ishiguro T, Sakamoto N. Experimental atherosclerosis-like lesions induced by hyperinsulinism in Wistar rats. Diabetes. 1989;38:91-96.
47. Bonithon-Kopp C, Touboul P-J, Berr C, Leroux C, Mainard F, Courbon D, Ducimetière P. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries: the vascular aging (EVA) study. Arterioscler Thromb Vasc Biol. 1996;16:310-316.
48. Ikeda K, Suzuki M, Ikebuchi M, Hara Y, Tsushima M, Yamamoto A, Harano Y, Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension. J Diabetes Complications. 1995;9:227-229.
49. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
50. Slyper AH. Low density lipoprotein density and atherosclerosis: unraveling the connection. JAMA. 1994;272:305-308.
51. Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA, Touboul PJ. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23:1705-1711.
52. Sosef MN, Bosch JG, van Oostayen J, Visser T, Reiber JHC, Rosendaal FR. Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness. Thromb Haemost. 1994; 72:250-254.
53. Whisnant JP, Homer D, Ingall MBBSTJ, Baker HL Jr, O'Fallon WM, Wiebers DO. Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. Stroke. 1990; 21:707-714.